🧪
Targeted Butyrate Supplementation for Microglial Phenotype Modulation
hypothesis
Created: 2026-04-02 20:53:40
By: import
Quality:
79%
✓ SciDEX
ID: hypothesis-h-3d545f4e
🧪 Hypothesis Details
Composite Score55%proposed
Confidence
70%
Novelty
60%
Feasibility
90%
Impact
80%
Targeted Butyrate Supplementation for Microglial Phenotype Modulation proposes leveraging the gut-brain axis to restore microglial homeostasis in neurodegenerative diseases through precision delivery of butyrate — a short-chain fatty acid (SCFA) produced by commensal gut bacteria. Parkinson's disease, Alzheimer's disease, and ALS are all associated with gut dysbiosis characterized by depletion of butyrate-producing bacterial species (Faecalibacterium prausnitzii, Roseburia intestinalis, Eubacter...
Related Entities
Parent Context
Metadata
| composite_score | 0.79 |
| target_gene | GPR109A |
| target_pathway | None |
| disease | neurodegeneration |
| status | proposed |
🌍 Provenance Graph
8 nodes, 14 edges
derives from (14)
...and 9 more
Linked Artifacts (1454)